Only a small fraction of people with mental health or substance-use disorders receive effective care

New research estimates that globally, only 6.9 per cent of people with mental health or substance-use disorders receive effective treatment for their disorders.

Dapagliflozin and calorie restriction show higher remission rates in type 2 diabetes

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction

January 23, 2025

Labcorp wins FDA OK for pan-solid tumor liquid biopsy

Dive Brief: Labcorp has received de novo authorization for a kitted, pan-solid tumor liquid biopsy test, the company said Friday. The product, PGDx elio plasma

August 6, 2024

Listen: A new obesity startup, an acquisition gone wrong, & the future of Teladoc

How does a startup compete with the likes of Eli Lilly and Novo Nordisk in the rapidly evolving field of weight loss drugs? And how

April 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.